Search

everythinglearnresearchcommunity

for

Search:↓

Mesotherapy might improve hair growth, but more research is needed to confirm its safety and effectiveness.

Gasdermin A3 causes hair follicle stem cells to activate too early, leading to hair loss.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Stress hormone stops a growth signal and keeps hair stem cells inactive, reducing hair growth.

Sweat glands and hair follicles are determined by opposing signals, with BMPs promoting sweat glands and blocking BMPs leading to hair follicles.

Stress hormone corticosterone suppresses hair growth by affecting stem cell activity and Gas6 protein expression.

Damaged hair follicle stem cells may leave the skin to help maintain youthfulness.

Certain factors can start hair growth in adult skin by making cells communicate and form new hair follicles.

FGF9 from certain T cells helps create new hair follicles during wound healing, which could potentially be used for hair loss treatments.

A substance called FGF9 from certain immune cells can trigger new hair growth during wound healing in mice, but humans may not have the same response due to fewer of these cells.

Bald men with male pattern baldness still have hair stem cells, but lack certain cells needed for hair growth.

Bald men with male pattern baldness still have hair stem cells, but lack certain cells needed for hair growth.

Bald men with male pattern baldness still have hair stem cells, but lack certain cells needed to grow hair.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Gut health may influence Alopecia Areata, suggesting new treatments.

Isotretinoin may effectively treat hereditary hypotrichosis simplex, a rare hair loss condition.

Wnt and Shh signaling are key in noggin-induced tumors, and blocking them can slow tumor growth.

Scientists created cell lines from balding patients and found that cells from the front of the scalp are more affected by hormones that cause hair loss than those from the back.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

SOX9 helps determine stem cell roles by interacting with DNA and proteins that control gene activity.

Eclipta alba L. (Urang-Aring) can help treat hair loss.

Higher levels of the protein Pannexin-1 may play a role in hair loss in women with PCOS.

A woman's hair loss was initially misdiagnosed as scarring hair loss but was actually a treatable autoimmune hair loss.